子宫和卵巢癌肉瘤-病例系列的临床、形态学和免疫组织化学研究。

IF 0.9 Q4 PHARMACOLOGY & PHARMACY
Journal of pharmacy & bioallied sciences Pub Date : 2025-06-01 Epub Date: 2025-06-18 DOI:10.4103/jpbs.jpbs_1658_24
Thamilselvi Ramachandran, Anbu Lenin Kulandaivel, Poovizhi Inbasekaran, Jayamani Baskaran, Panneerselvam Periasamy
{"title":"子宫和卵巢癌肉瘤-病例系列的临床、形态学和免疫组织化学研究。","authors":"Thamilselvi Ramachandran, Anbu Lenin Kulandaivel, Poovizhi Inbasekaran, Jayamani Baskaran, Panneerselvam Periasamy","doi":"10.4103/jpbs.jpbs_1658_24","DOIUrl":null,"url":null,"abstract":"<p><p>Ovarian carcinosarcoma (MMMT-malignant mixed Müllerian tumors) is highly aggressive, rare tumor, affecting postmenopausal women with the incidence peak in the sixth decade with significant morbidity and mortality. Uterine carcinosarcomas are rare tumors comprising less than 5% of uterine malignancies. Ovarian cancer is the seventh cause of death and morbidity in females worldwide.To study about the clinical, morphological, and immunohistochemical study of case series of ovarian and uterine carcinosarcoma. Retrospective study of three cases. In first case a 50-year-old woman presented with a left ovarian tumor with a clinical diagnosis of carcinoma of ovary, USG-malignant ovarian tumor. Cancer antigen-125 (Ca-125) was elevated. She underwent surgery and final diagnosis was ovarian carcinosarcoma with high-grade papillary serous carcinoma of endometrium. In second case a 56-year-old woman presented with mass descending per vaginum-three years, abdominal pain-three months. Clinical diagnosis of malignant tumor of the right ovary was made. Ca-125 was elevated. She underwent surgery and the final diagnosis was right ovarian carcinosarcoma with a heterologous component and omental metastatic deposit. In third case a 48-year-old woman presented with continuous bleeding per vaginum for two months. Diagnosed as abnormal uterine bleeding- leiomyoma. She underwent panhysterectomy with lymph nodes removal and final diagnosis was uterine carcinosarcoma. Ovarian carcinosarcomas are very aggressive tumors that are usually diagnosed at an advanced stage due to its asymptomatic nature, its lack of active screening, and early detection techniques. The survival rate after diagnosis varies by stage of disease and uterine and ovarian carcinosarcomas.er horizons involving younger patients with asymptomatic severe AS, and long term outcomes of valve durability and moderate AS in combination with cardiac failure bicuspid aortic valve stenosis and pure native aortic regurgitation are however still under research.</p>","PeriodicalId":94339,"journal":{"name":"Journal of pharmacy & bioallied sciences","volume":"17 Suppl 2","pages":"S2021-S2024"},"PeriodicalIF":0.9000,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12244588/pdf/","citationCount":"0","resultStr":"{\"title\":\"Carcinosarcoma of Uterus and Ovary-Clinical, Morphological, and Immunohistochemical Study of Case Series.\",\"authors\":\"Thamilselvi Ramachandran, Anbu Lenin Kulandaivel, Poovizhi Inbasekaran, Jayamani Baskaran, Panneerselvam Periasamy\",\"doi\":\"10.4103/jpbs.jpbs_1658_24\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Ovarian carcinosarcoma (MMMT-malignant mixed Müllerian tumors) is highly aggressive, rare tumor, affecting postmenopausal women with the incidence peak in the sixth decade with significant morbidity and mortality. Uterine carcinosarcomas are rare tumors comprising less than 5% of uterine malignancies. Ovarian cancer is the seventh cause of death and morbidity in females worldwide.To study about the clinical, morphological, and immunohistochemical study of case series of ovarian and uterine carcinosarcoma. Retrospective study of three cases. In first case a 50-year-old woman presented with a left ovarian tumor with a clinical diagnosis of carcinoma of ovary, USG-malignant ovarian tumor. Cancer antigen-125 (Ca-125) was elevated. She underwent surgery and final diagnosis was ovarian carcinosarcoma with high-grade papillary serous carcinoma of endometrium. In second case a 56-year-old woman presented with mass descending per vaginum-three years, abdominal pain-three months. Clinical diagnosis of malignant tumor of the right ovary was made. Ca-125 was elevated. She underwent surgery and the final diagnosis was right ovarian carcinosarcoma with a heterologous component and omental metastatic deposit. In third case a 48-year-old woman presented with continuous bleeding per vaginum for two months. Diagnosed as abnormal uterine bleeding- leiomyoma. She underwent panhysterectomy with lymph nodes removal and final diagnosis was uterine carcinosarcoma. Ovarian carcinosarcomas are very aggressive tumors that are usually diagnosed at an advanced stage due to its asymptomatic nature, its lack of active screening, and early detection techniques. The survival rate after diagnosis varies by stage of disease and uterine and ovarian carcinosarcomas.er horizons involving younger patients with asymptomatic severe AS, and long term outcomes of valve durability and moderate AS in combination with cardiac failure bicuspid aortic valve stenosis and pure native aortic regurgitation are however still under research.</p>\",\"PeriodicalId\":94339,\"journal\":{\"name\":\"Journal of pharmacy & bioallied sciences\",\"volume\":\"17 Suppl 2\",\"pages\":\"S2021-S2024\"},\"PeriodicalIF\":0.9000,\"publicationDate\":\"2025-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12244588/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of pharmacy & bioallied sciences\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4103/jpbs.jpbs_1658_24\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/6/18 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q4\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of pharmacy & bioallied sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/jpbs.jpbs_1658_24","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/6/18 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

摘要

卵巢癌肉瘤(mmmt -恶性混合性勒氏肿瘤)是一种侵袭性强、罕见的肿瘤,多发于绝经后妇女,发病率高峰在60岁左右,发病率和死亡率均较高。子宫癌肉瘤是一种罕见的肿瘤,占子宫恶性肿瘤的不到5%。卵巢癌是全世界女性死亡和发病的第七大原因。目的:探讨卵巢、子宫癌肉瘤病例系列的临床、形态学和免疫组化研究。回顾性分析3例病例。在第一个病例中,一位50岁的女性表现为左侧卵巢肿瘤,临床诊断为卵巢癌,usg恶性卵巢肿瘤。癌抗原125 (Ca-125)升高。她接受了手术,最终诊断为卵巢癌肉瘤合并子宫内膜高级别乳头状浆液性癌。第二例为56岁女性,每阴道肿块下降3年,腹痛3个月。对右卵巢恶性肿瘤进行临床诊断。Ca-125升高。她接受了手术,最终诊断为右卵巢肉瘤伴异源成分和大网膜转移沉积。第三例患者为48岁女性,阴道连续出血2个月。诊断为子宫异常出血-平滑肌瘤。她接受了全子宫切除术和淋巴结切除,最终诊断为子宫癌肉瘤。卵巢癌肉瘤是一种侵袭性很强的肿瘤,由于其无症状、缺乏主动筛查和早期发现技术,通常在晚期才被诊断出来。诊断后的生存率因疾病分期和子宫、卵巢肉瘤而异。然而,涉及无症状严重AS的年轻患者,以及瓣膜耐久性和中度AS合并心力衰竭的长期结果,双尖瓣主动脉瓣狭窄和纯粹的原生主动脉反流仍在研究中。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Carcinosarcoma of Uterus and Ovary-Clinical, Morphological, and Immunohistochemical Study of Case Series.

Carcinosarcoma of Uterus and Ovary-Clinical, Morphological, and Immunohistochemical Study of Case Series.

Carcinosarcoma of Uterus and Ovary-Clinical, Morphological, and Immunohistochemical Study of Case Series.

Carcinosarcoma of Uterus and Ovary-Clinical, Morphological, and Immunohistochemical Study of Case Series.

Ovarian carcinosarcoma (MMMT-malignant mixed Müllerian tumors) is highly aggressive, rare tumor, affecting postmenopausal women with the incidence peak in the sixth decade with significant morbidity and mortality. Uterine carcinosarcomas are rare tumors comprising less than 5% of uterine malignancies. Ovarian cancer is the seventh cause of death and morbidity in females worldwide.To study about the clinical, morphological, and immunohistochemical study of case series of ovarian and uterine carcinosarcoma. Retrospective study of three cases. In first case a 50-year-old woman presented with a left ovarian tumor with a clinical diagnosis of carcinoma of ovary, USG-malignant ovarian tumor. Cancer antigen-125 (Ca-125) was elevated. She underwent surgery and final diagnosis was ovarian carcinosarcoma with high-grade papillary serous carcinoma of endometrium. In second case a 56-year-old woman presented with mass descending per vaginum-three years, abdominal pain-three months. Clinical diagnosis of malignant tumor of the right ovary was made. Ca-125 was elevated. She underwent surgery and the final diagnosis was right ovarian carcinosarcoma with a heterologous component and omental metastatic deposit. In third case a 48-year-old woman presented with continuous bleeding per vaginum for two months. Diagnosed as abnormal uterine bleeding- leiomyoma. She underwent panhysterectomy with lymph nodes removal and final diagnosis was uterine carcinosarcoma. Ovarian carcinosarcomas are very aggressive tumors that are usually diagnosed at an advanced stage due to its asymptomatic nature, its lack of active screening, and early detection techniques. The survival rate after diagnosis varies by stage of disease and uterine and ovarian carcinosarcomas.er horizons involving younger patients with asymptomatic severe AS, and long term outcomes of valve durability and moderate AS in combination with cardiac failure bicuspid aortic valve stenosis and pure native aortic regurgitation are however still under research.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
1.40
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信